Noradrenalin Aguettant (Noradrenaline Tartrate)

Noradrenaline tartrate, the active ingredient in Noradrenalin Aguettant, is a sympathomimetic catecholamine presented as an intravenous solution for intravenous use. It is employed to raise blood pressure in acute hypotensive states and to support circulation during shock and cardiac arrest.

GNH USA supplies Noradrenalin Aguettant as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Noradrenalin Aguettant acts on the sympathetic cardiovascular pathway to correct severe hypotension and shock.

Acute hypotension: rapidly increases systemic vascular resistance to restore arterial pressure. Septic shock: supports perfusion when endogenous catecholamine response is insufficient. Cardiac arrest: provides vasoconstriction and modest inotropic support during resuscitation. Post‑operative hypotension: stabilises blood pressure after major surgery.

Adverse reactions may occur with intravenous administration of noradrenaline.

Common Side Effects: - Headache: transient and dose‑related. - Tachycardia: increased heart rate due to β1 stimulation. - Peripheral ischemia: reduced blood flow to extremities. - Nausea: mild gastrointestinal upset. - Anxiety: feeling of restlessness or nervousness.

Serious or Rare Side Effects: - Cardiac arrhythmias: potentially life‑threatening rhythm disturbances. - Severe hypertension: excessive rise in blood pressure. - Tissue necrosis: from extravasation at the infusion site. - Myocardial ischemia: reduced coronary perfusion. - Pulmonary edema: fluid accumulation in lungs.

Noradrenalin Aguettant requires careful monitoring and specific safety measures.

Blood pressure monitoring: continuously assess arterial pressure during infusion. Cardiac function: evaluate heart rhythm and contractility before and during use. Extravasation risk: administer through a central line when possible. Dose titration: adjust infusion rate to achieve target hemodynamics. Contraindications: avoid in patients with known hypersensitivity to catecholamines. Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Noradrenalin may interact with several drug classes, altering its efficacy or safety profile.

Major Interactions (Avoid): - Beta‑blockers: may blunt the inotropic response and precipitate severe hypotension. - MAO inhibitors: increase risk of hypertensive crisis. - Tricyclic antidepressants: potentiate vasoconstrictive effects.

Moderate Interactions (Monitor Closely): - Vasodilators (e.g., nitroglycerin): may require higher noradrenaline doses. - Calcium channel blockers: can affect vascular tone and heart rate. - Diuretics: may exacerbate electrolyte shifts influencing cardiovascular response.